Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Comment by Candyswanwickson Feb 17, 2017 1:34am
217 Views
Post# 25859459

RE:RE:RE:RE:RE:RE:RE:RE:SP

RE:RE:RE:RE:RE:RE:RE:RE:SP
Dear Cavsin,


cavinsin wrote: Some fundamentals, that most of investors will look into,  before they buy into business
Market Cap 1.5B
Revenue under 5M
Shares outstanding 142M
Earnings per share 0.14c
Cash on hand 700M plus
P/E  ratio 75x
Price/Sales 340
Price/Cash flow 90x
Realistic share price $ 6.00 in my opinion
Rest is speculation, I see here on this board some are calling $ 40.00 per sahre this year. Like to hear their explanation
can you reed financials, or do you keep your fingers crossed, ? looks like you prefer too roll a dice.
Dont take me wrong I do that some time as well, and I can afford to loose



a company is worth as much as its future projected cash flow. That 750 mil will turn into cash flow over time with Goodman's acquisitions. What has goodman done wrong execution wise with running Paladin or Knights? Intelligent management is the most important thing and our only gauge as non insiders is management making good promises and keeping them.... People know it might be a while before they see SP move... only one person PT'd 40 dollars. The second highest was 20. It's hard to gauge PT because we aren't insiders and don't know when and how the 750 mil will go to work. 
Also, I think you said Paladin was luck because it went for $140 Canadian and $90 Us!? who really cares? I'll take 90 dollars a share Canadian for knights 5 years down the road. What's your the deal dude? No one here wants to be saved from GUD...go away, or explain why you're bashing, full disclosure.
Bullboard Posts